Conditional gene expression in hepatitis C virus transgenic mice without induction of severe liver injury using a non-inflammatory Cre-expressing adenovirus

Virus Research

Volumn 160, Issue 1-2, 2011, Pages 89-97

  Chiyo, Tomoko ^a   Sekiguchi, Satoshi ^a   Hayashi, Masahiro ^a   Tobita, Yoshimi ^a   Kanegae, Yumi ^b   Saito, Izumu ^b   Kohara, Michinori ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cre loxP system; EF1 promoter; HCV transgenic mouse; Hepatitis; Recombinant adenovirus vector

Indexed keywords

ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; CRE RECOMBINASE; VIRUS PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; DNA RECOMBINATION; HEPATITIS; HEPATITIS C VIRUS; HEPATITIS C VIRUS TRANSGENIC MOUSE; HUMAN; HUMAN CELL; LOXP SITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS C; INTEGRASES; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

ADENOVIRIDAE; HEPATITIS C VIRUS; MUS; MUS MUSCULUS;

EID: 80052178313     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.05.019     Document Type: Article

References (28)

1. Akagi K., Sandig V., Vooijs M., Van der Valk M., Giovannini M., Strauss M., Berns A. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res. 1997, 25(9):1766-1773.
2. Baba Y., Nakano M., Yamada Y., Saito I., Kanegae Y. Practical range of effective dose for Cre recombinase-expressing recombinant adenovirus without cell toxicity in mammalian cells. Microbiol. Immunol. 2005, 49(6):559-570.
3. Bangari D.S., Mittal S.K. Current strategies and future directions for eluding adenoviral vector immunity. Curr. Gene Ther. 2006, 6(2):215-226.
4. Ernst E., Schonig K., Bugert J.J., Blaker H., Pfaff E., Stremmel W., Encke J. Generation of inducible hepatitis C virus transgenic mouse lines. J. Med. Virol. 2007, 79(8):1103-1112.
5. Goodman Z.D., Ishak K.G. Histopathology of hepatitis C virus infection. Semin. Liver Dis. 1995, 15(1):70-81.
6. Ho K.J., Bass C.E., Kroemer A.H., Ma C., Terwilliger E., Karp S.J. Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295(2):G412-G419.
7. Kafri T., Morgan D., Krahl T., Sarvetnick N., Sherman L., Verma I. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc. Natl. Acad. Sci. U S A 1998, 95(19):11377-11382.
8. Kanegae Y., Lee G., Sato Y., Tanaka M., Nakai M., Sakaki T., Sugano S., Saito I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 1995, 23(19):3816-3821.
9. Kanegae Y., Makimura M., Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 1994, 47(3):157-166.
10. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., Kiernan T.W., Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1(5):431-435.
11. Kobayashi N., Fujiwara T., Westerman K.A., Inoue Y., Sakaguchi M., Noguchi H., Miyazaki M., Cai J., Tanaka N., Fox I.J., Leboulch P. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000, 287(5456):1258-1262.
12. Kremsdorf D., Brezillon N. New animal models for hepatitis C viral infection and pathogenesis studies. World J. Gastroenterol. 2007, 13(17):2427-2435.
13. Lerat H., Honda M., Beard M.R., Loesch K., Sun J., Yang Y., Okuda M., Gosert R., Xiao S.Y., Weinman S.A., Lemon S.M. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 2002, 122(2):352-365.
14. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 1998, 4(9):1065-1067.
15. Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Ishibashi K., Matsuura Y., Miyamura T., Koike K. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 1997, 78(7):1527-1531.
16. Nakai M., Komiya K., Murata M., Kimura T., Kanaoka M., Kanegae Y., Saito I. Expression of pIX gene induced by transgene promoter: possible cause of host immune response in first-generation adenoviral vectors. Hum. Gene. Ther. 2007, 18(10):925-936.
17. Palmer D.J., Ng P. Helper-dependent adenoviral vectors for gene therapy. Hum. Gene. Ther. 2005, 16(1):1-16.
18. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 2005, 5(9):558-567.
19. Shintani Y., Yotsuyanagi H., Moriya K., Fujie H., Tsutsumi T., Kanegae Y., Kimura S., Saito I., Koike K. Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system. J. Gen. Virol. 1999, 80(12):3257-3265.
20. Sun J., Bodola F., Fan X., Irshad H., Soong L., Lemon S.M., Chan T.S. Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J. Virol. 2001, 75(24):11992-11998.
21. Sun J., Tumurbaatar B., Jia J., Diao H., Bodola F., Lemon S.M., Tang W., Bowen D.G., McCaughan G.W., Bertolino P., Chan T.S. Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury. J. Virol. 2005, 79(16):10730-10739.
22. Takaku S., Nakagawa Y., Shimizu M., Norose Y., Maruyama I., Wakita T., Takano T., Kohara M., Takahashi H. Induction of hepatic injury by hepatitis C-virus-specific CD8± murine cytotoxic T lymphocytes in transgenic mice expressing the viral structural genes. Biochem. Biophys. Res. Commun. 2003, 301:330-337.
23. Takeuchi T., Katsume A., Tanaka T., Abe A., Inoue K., Tsukiyama-Kohara K., Kawaguchi R., Tanaka S., Kohara M. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 1999, 116(3):636-642.
24. Tumurbaatar B., Sun Y., Chan T., Sun J. Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice. J. Virol. Methods 2007, 146(1-2):5-13.
25. Wakita T., Katsume A., Kato J., Taya C., Yonekawa H., Kanegae Y., Saito I., Hayashi Y., Koike M., Miyamoto M., Hiasa Y., Kohara M. Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system. J. Med. Virol. 2000, 62(3):308-317.
26. Wakita T., Taya C., Katsume A., Kato J., Yonekawa H., Kanegae Y., Saito I., Hayashi Y., Koike M., Kohara M. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J. Biol. Chem. 1998, 273(15):9001-9006.
27. Yang Y., Ertl H.C., Wilson J.M. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994, 1(5):433-442.
28. Zhu H.Z., Wang W., Feng D.M., Sai Y., Xue J.L. Conditional gene modification in mouse liver using hydrodynamic delivery of plasmid DNA encoding Cre recombinase. FEBS Lett. 2006, 580(18):4346-4352.